| Literature DB >> 27986871 |
Arevik Mosoian1, Lumin Zhang1, Feng Hong1, Francesc Cunyat2, Adeeb Rahman1, Riti Bhalla1, Ankur Panchal1, Yedidya Saiman1, M Isabel Fiel3, Sander Florman4, Sasan Roayaie5, Myron Schwartz5, Andrea Branch1, Mario Stevenson2, Meena B Bansal6.
Abstract
End-stage liver disease is a common cause of non-AIDS-related mortality in HIV+ patients, despite effective anti-retroviral therapies (ARTs). HIV-1 infection causes gut CD4 depletion and is thought to contribute to increased gut permeability, bacterial translocation, and immune activation. Microbial products drain from the gut into the liver via the portal vein where Kupffer cells (KCs), the resident liver macrophage, clear translocated microbial products. As bacterial translocation is implicated in fibrogenesis in HIV patients through unclear mechanisms, we tested the hypothesis that HIV infection of KCs alters their response to LPS in a TLR4-dependent manner. We showed that HIV-1 productively infected KCs, enhanced cell-surface TLR4 and CD14 expression, and increased IL-6 and TNF-α expression, which was blocked by a small molecule TLR4 inhibitor. Our study demonstrated that HIV infection sensitizes KCs to the proinflammatory effects of LPS in a TLR4-dependent manner. These findings suggest that HIV-1-infected KCs and their dysregulated innate immune response to LPS may play a role in hepatic inflammation and fibrosis and represent a novel target for therapy. © Society for Leukocyte Biology.Entities:
Keywords: HIV-induced hepatic inflammation; liver fibrosis; microbial translocation
Mesh:
Substances:
Year: 2016 PMID: 27986871 PMCID: PMC5380374 DOI: 10.1189/jlb.3HI0516-242R
Source DB: PubMed Journal: J Leukoc Biol ISSN: 0741-5400 Impact factor: 6.011